Abstract: A prostatic stent for treating benign prostatic hypertrophy (BPH) is disclosed. The stent comprises a first ring constructed of tubing; a second ring constructed of tubing; and a plurality of connecting arm members connecting said first and second rings such that the plane of said first ring is maintained substantially parallel to the plane of said second ring. In operation and use, the first ring is placed in the bladder of a patient with BPH, the second ring is placed in the prostatic urethra and the connecting arms hold back a hypertrophied prostate and prevent it from closing off the prostatic urethra.